Search This Blog

Sunday, July 21, 2019

Insurers May Cover Statins, SSRIs, Inhalers at 100% Under Trump Notice

In a win for the health savings account industry and consumers with certain chronic illnesses, the Trump Treasury Department has broadened the list of preventative care items that may be covered at 100% under a high-deductible health plan before the deductible kicks in. But whether insurers will absorb the new costs or pass them on to employers and consumers in premium increases is a big unknown.
Notice 2019-45, Additional Preventative Care Benefits Permitted to be Provided by a High Deductible Health Plan, is effective immediately. That’s important because now is when health insurance companies and employers are setting up plans together for the 2020 plan year.
The thinking is that more employers will move toward high-deductible health insurance plans, with accompanying health savings accounts—and more employees will choose them–if these plans cover more preventative services before the deductible. Before, if a plan included these preventative services, it wouldn’t be an HSA-eligible plan.
“It’s opening up HSAs to more people, on the face of it; that’s what we would expect,” says Shobin Uralil, cofounder of health savings account provider Lively. By opening and contributing to an HSA, consumers can pay for immediate or future health care expenses with big tax savings.
The notice “does not expand the scope of preventive care beyond the list.” So if you’re thinking, well, if SSRIs are covered, SNRIs should be covered, too–tough luck. And the notice makes clear that prior notices on preventative care are still in force (vasectomies are not preventative; that’s Notice 2018-12). Also, note that the services/meds must be prescribed in relation to a specific diagnosis. Here’s the list:
Preventive Care for Specified ConditionsFor Individuals Diagnosed with
Angiotensin Converting Enzyme (ACE) inhibitorsCongestive heart failure, diabetes, and/or coronary artery disease
Anti-resorptive therapyOsteoporosis and/or osteopenia
Beta-blockersCongestive heart failure and/or coronary artery disease
Blood pressure monitorHypertension
Inhaled corticosteroidsAsthma
Insulin and other glucose lowering agentsDiabetes
Retinopathy screeningDiabetes
Peak flow meterAsthma
GlucometerDiabetes
Hemoglobin A1c testingDiabetes
International Normalized Ratio (INR) testingLiver disease and/or bleeding disorders
Low-density Lipoprotein (LDL) testingHeart disease
Selective Serotonin Reuptake Inhibitors (SSRIs)Depression
StatinsHeart disease and/or diabetes
The Treasury and the IRS, in consultation with HHS, will review the list every five to ten years to make additions or deletions.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.